Medallion Fund Strategy, Returns, and Holdings: Top 5 Stock Picks

3. Gilead Sciences, Inc. (NASDAQ:GILD)

Renaissance Technologies Investment In Q1 2023: $878 million

Gilead Sciences, Inc. (NASDAQ:GILD) is a biotechnology company that develops treatments for a variety of diseases such as cancer and blood pressure problems. Its shares are rated Buy on average. Mr. Simons’ hedge fund owned an $878 million stake in the firm during this year’s first quarter.

60 of the 943 hedge funds covered by Insider Monkey had also invested in Gilead Sciences, Inc. (NASDAQ:GILD) by then, with the firm’s second largest hedge fund shareholder being Peter Rathjens, Bruce Clarke, and John Campbell’s Arrowstreet Capital since it owned 8.1 million shares worth $679 million.

Follow Gilead Sciences Inc. (NASDAQ:GILD)